Coronary stenting and surgery: Perioperative management of antiplatelet therapy in patients undergoing surgery after coronary stent implantation;Stent coronarico e chirurgia: La gestione perioperatoria della terapia antiaggregante nel paziente portatore di stent coronarico candidato a intervento chirurgico

Giornale Italiano di Cardiologia

Volumn 13, Issue 7-8, 2012, Pages 528-551

  Rossini, Roberta ^a   Bramucci, Ezio ^b   Castiglioni, Battistina ^c   De Servi, Stefano ^d   Lettieri, Corrado ^e   Lettino, Maddalena ^f   Musumeci, Giuseppe ^a   Visconti, Luigi Oltrona ^b   Piccaluga, Emanuela ^g   Savonitto, Stefano ^h   Trabattoni, Daniela ⁱ   Buffoli, Francesca ^e   Angiolillo, Dominick J ^j   Bovenzi, Francesco ^k   Cremonesi, Alberto ^l   Scherillo, Marino ^m   Guagliumi, Giulio ^a   Gerometta, Piersilvio ⁿ   Parolari, Alessandro ^o   Dionigi, Gianlorenzo ^p   Boni, Luigi ^p   Guffanti, Enrico ^c   Biglioli, Federico ^q   Beltramini, Giada ^q   Valdatta, Luigi ^p   Devalle, Luca ^a   Droghetti, Andrea ^e   Bozzani, Antonio ^b   Ravelli, Paolo ^a   Crescini, Claudio ^r   Staurenghi, Giovanni ^g   Gaini, Sergiomaria ^s   Scarone, Pietro ^s   Francetti, Luca ^o   Corbella, Stefano ^o   D'Angelo, Fabio ^p   Comel, Andrea ^e   Gadda, Franco ^s   Salvi, Luca ⁱ   Castelli, Antonio ^g   Menozzi, Emanuela ^g   Bartoli, Stefano ^t   Presenti, Luigi ^u   Longoni, Mauro ^v   Soncini, Marco ^w   Spinzi, Giancarlo ^x   Vecchi, Maurizio ^y   Ferronato, Giuseppe ^z   Robotti, Enrico ^a   Dell'Amore, Davide ^aa   Setacci, Carlo ^ab   Melotti, Gianluigi ^ac   Cherubino, Paolo ^p   Rocco, Francesco ^s   Servadei, Franco ^ad   Creperio, Giampietro ^ae   more..

^a OSPEDALI RIUNITI   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c OSPEDALE DI CIRCOLO   (Italy)

^d Azienda Ospedaliera di Legnano   (Italy)

^e CARLO POMA HOSPITAL   (Italy)

^f HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^g UNIVERSITY OF MILAN   (Italy)

^h S MARIA NUOVA HOSPITAL   (Italy)

ⁱ CENTRO CARDIOLOGICO MONZINO   (Italy)

^j UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^k CAMPO DI MARTE HOSPITAL   (Italy)

^l Research Ettore Sansavini Health Science Foundation   (Italy)

^m Clinic Center   (Italy)

ⁿ Humanitas Gavazzeni Hospital   (Italy)

^o UNIVERSITY OF MILAN   (Italy)

^p UNIVERSITY OF INSUBRIA   (Italy)

^q SAN PAOLO HOSPITAL   (Italy)

^r Ospedale di S Giovanni Bianco (BG)   (Italy)

^s FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^t Chirurgia Vascolare ASL RMC   (Italy)

^u Giovanni Paolo II Hospital   (Italy)

^v PARKINSON INSTITUTE   (Italy)

^w SAN CARLO BORROMEO HOSPITAL   (Italy)

^x VALDUCE HOSPITAL   (Italy)

^y IRCCS POLICLINICO SAN DONATO   (Italy)

^z UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^aa MORGAGNI PIERANTONI HOSPITAL   (Italy)

^ab UNIVERSITY OF SIENA   (Italy)

^ac Gastrointestinal Endoscopy Unit   (Italy)

^ad UNIVERSITY HOSPITAL OF PARMA   (Italy)

^ae Ospedale Erba Renaldi di Menaggio CO   (Italy)

more..

Author keywords

Aspirin; Clopidogrel; Coronary heart disease; Stent; Surgery

Indexed keywords

ANTITHROMBOCYTIC AGENT; EPTIFIBATIDE; TIROFIBAN;

ANTICOAGULANT THERAPY; BARE METAL STENT; BLEEDING; CORONARY ARTERY SURGERY; CORONARY STENT; DRUG ELUTING STENT; DRUG WITHDRAWAL; HEART MUSCLE ISCHEMIA; HUMAN; IMPLANTATION; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; STENT THROMBOSIS;

CORONARY DISEASE; HUMANS; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; RISK ASSESSMENT; RISK FACTORS; STENTS; SURGICAL PROCEDURES, OPERATIVE;

EID: 84864809495     PISSN: 18276806     EISSN: 19726481     Source Type: Journal    
DOI: 10.1714/1114.12251     Document Type: Review

References (164)

1. Wijns W, Kolh P, Danchin N, et al.; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI). Guidelines on myocardial revascularization. Eur Heart J 2010;31:2501-55.
2. Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2009;53:530-53.
3. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-21. (Pubitemid 39410418)
4. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30. (Pubitemid 40617065)
5. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006;113:2803-9. (Pubitemid 44305292)
6. van Werkum JW, Heestermans AA, Zomer AC, et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol 2009;53:1399-409.
7. Roger VL, Go AS, Lloyd-Jones DM, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation 2012;125: e2-e220.
8. Moschovitis A, Cook S, Meier B. Percutaneous coronary interventions in Europe in 2006. EuroIntervention 2010;6:189-94.
9. Savonitto S, Caracciolo M, Cattaneo M, De Servi S. Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery. J Thromb Haemost 2011;9: 2133-42.
10. Yusuf S, Zhao F, Mehta SR, et al.; CURE Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502. (Pubitemid 32758501)
11. Rossini R, Capodanno D, Lettieri C, et al. Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation. Am J Cardiol 2011;107: 186-94.
12. Vicenzi MN, Meislitzer T, Heitzinger B, Halaj M, Fleisher LA, Metzler H. Coronary artery stenting and non-cardiac surgery - a prospective outcome study. Br J Anaesth 2006;96:686-93. (Pubitemid 43786682)
13. Berger PB, Kleiman NS, Pencina MJ, et al.; EVENT Investigators. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement: results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv 2010;3:920-7.
14. To AC, Armstrong G, Zeng I, Webster MW. Noncardiac surgery and bleeding after percutaneous coronary intervention. Circ Cardiovasc Interv 2009;2:213-21.
15. Cruden NL, Harding SA, Flapan AD, et al.; Scottish Coronary Revascularisation Register Steering Committee. Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ Cardiovasc Interv 2010;3:236-42.
16. Anwaruddin S, Askari AT, Saudye H, et al. Characterization of post-operative risk associated with prior drug-eluting stent use. JACC Cardiovasc Interv 2009;2:542-9.
17. Brilakis ES, Cohen DJ, Kleiman NS, et al. Incidence and clinical outcome of minor surgery in the year after drug-eluting stent implantation: results from the Evaluation of Drug-Eluting Stents and Ischemic Events Registry. Am Heart J 2011;161:360-6.
18. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990;72:153-84. (Pubitemid 20031326)
19. Kumar R, McKinney WP, Raj G, et al. Adverse cardiac events after surgery: assessing risk in a veteran population. J Gen Intern Med 2001;16:507-18. (Pubitemid 34203389)
20. Badner NH, Knill RL, Brown JE, Novick TV, Gelb AW. Myocardial infarction after noncardiac surgery. Anesthesiology 1998; 88:572-8. (Pubitemid 28120188)
21. Shah KB, Kleinman BS, Rao TL, Jacobs HK, Mestan K, Schaafsma M. Angina and other risk factors in patients with cardiac diseases undergoing noncardiac operations. Anesth Analg 1990;70:240-7. (Pubitemid 20185106)
22. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002;324:71-86.
23. Beving H, Zhao C, Albage A, Ivert T. Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment. Blood Coagul Fibrinolysis 1996;7:80-4. (Pubitemid 26106173)
24. Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and metaanalysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease. Eur Heart J 2006;27:2667-74. (Pubitemid 44729867)
25. Priebe HJ. Triggers of perioperative myocardial ischaemia and infarction. Br J Anaesth 2004;93:9-20.
26. Dahl OE. Mechanisms of hypercoagulability. Thromb Haemost 1999;82:902-6.
27. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003;75:S715-S720. (Pubitemid 36184553)
28. Oscarsson A, Gupta A, Fredrikson M, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth 2010; 104:305-12.
29. Mangano DT; Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002;347:1309-17.
30. Topol EJ. Aspirin for bypass surgery - from taboo to new standard of care. N Engl J Med 2002;347:1359-60. (Pubitemid 35215328)
31. Firanescu CE, Martens EJ, Schonberger JP, Soliman Hamad MA, van Straten AH. Postoperative blood loss in patients undergoing coronary artery bypass surgery after preoperative treatment with clopidogrel. A prospective randomised controlled study. Eur J Cardiothorac Surg 2009;36:856-62.
32. Albaladejo P, Marret E, Samama CM, et al. Non-cardiac surgery in patients with coronary stents: the RECO study. Heart 2011;97:1566-72.
33. Artang R, Dieter RS. Analysis of 36 reported cases of late thrombosis in drugeluting stents placed in coronary arteries. Am J Cardiol 2007;99:1039-43. (Pubitemid 46560471)
34. Schouten O, van Domburg RT, Bax JJ, et al. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 2007;49:122-4. (Pubitemid 46026891)
35. van Kuijk JP, Flu WJ, Schouten O, et al. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents. Am J Cardiol 2009;104:1229-34.
36. Rabbitts JA, Nuttall GA, Brown MJ, et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008; 109:596-604.
37. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'Neill WW. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000;343:915-22.
38. Cutlip DE, Windecker S, Mehran R, et al.; Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007; 115:2344-51. (Pubitemid 46685903)
39. Chassot PG, Delabays A, Spahn DR. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction Br J Anaesth 2007;99: 316-28. (Pubitemid 47321534)
40. Singh M, Mehta N, Murthy UK, Kaul V, Arif A, Newman N. Postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel therapy. Gastrointest Endosc 2010;71:998-1005.
41. Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med 2005; 257:399-414. (Pubitemid 40604544)
42. Lindblad B, Persson NH, Takolander R, Bergqvist D. Does low-dose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind, placebo-controlled randomized trial. Stroke 1993;24:1125-8. (Pubitemid 23237547)
43. Thurston AV, Briant SL. Aspirin and post-prostatectomy haemorrhage. Br J Urol 1993;71:574-6. (Pubitemid 23172054)
44. Hui CK, Lai KC, Yuen MF, Wong WM, Lam SK, Lai CL. Does withholding aspirin for one week reduce the risk of post-sphincterotomy bleeding? Aliment Pharmacol Ther 2002;16:929-36.
45. Sun JCJ, Whitlock R, Cheng J, et al. The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies. Eur Heart J 2008;29: 1057-71. (Pubitemid 351858412)
46. Fox KA, Mehta SR, Peters R, et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 2004;110:1202-8. (Pubitemid 39202333)
47. Berger JS, Frye CB, Harshaw Q, Edwards FH, Steinhubl SR, Becker RC. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis. J Am Coll Cardiol 2008;52:1693-701.
48. Kapetanakis EI, Medlam DA, Boyce SW, et al. Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache? Eur Heart J 2005;26:576-83. (Pubitemid 40461099)
49. Mehta RH, Roe MT, Mulgund J, et al. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. J Am Coll Cardiol 2006;48:281-6.
50. Ebrahimi R, Dyke C, Mehran R, et al. Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol 2009;53:1965-72.
51. Kim JH, Newby LK, Clare RM, et al. Clopidogrel use and bleeding after coronary artery bypass graft surgery. Am Heart J 2008;156:886-92.
52. Hamm CW, Bassand JP, Agewall S, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.
53. Fitchett D, Eikelboom J, Fremes S, et al. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society. Can J Cardiol 2009;25:683-9.
54. Wilson SH, Fasseas P, Orford JL, et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003;42:234-40. (Pubitemid 36851411)
55. Osta WA, Akbary H, Fuleihan SF. Epidural analgesia in vascular surgery patients actively taking clopidogrel. Br J Anaesth 2010;104:429-32.
56. Ben-David B. Complications of regional anesthesia: an overview. Anesthesiol Clin North America 2002;20:665-7,ix.
57. Litz RJ, Gottschlich B, Stehr SN. Spinal epidural hematoma after spinal anesthesia in a patient treated with clopidogrel and enoxaparin. Anesthesiology 2004;101:1467-70. (Pubitemid 39565006)
58. Tam NL, Pac-Soo C, Pretorius PM. Epidural haematoma after a combined spinal-epidural anaesthetic in a patient treated with clopidogrel and dalteparin. Br J Anaesth 2006;96:262-5. (Pubitemid 43174671)
59. Barton MB, Miller T, Wolff T, et al.; US Preventive Services Task Force. How to read the new recommendation statement: methods update from the US Preventive Services Task Force. Ann Intern Med 2007;147:123-7. (Pubitemid 351664615)
60. Giannarini G, Mogorovich A, Valent F, et al. Continuing or discontinuing low-dose aspirin before transrectal prostate biopsy: results of a prospective randomized trial. Urology 2007;70:501-5. (Pubitemid 47464487)
61. Maan Z, Cutting CW, Patel U, et al. Morbidity of transrectal ultrasonographyguided prostate biopsies in patients after the continued use of low-dose aspirin. BJU Int 2003;91:798-800. (Pubitemid 36724062)
62. Halliwell OT, Yadegafar G, Lane C, Dewbury KC. Transrectal ultrasound-guided biopsy of the prostate: aspirin increases the incidence of minor bleeding complications. Clin Radiol 2008;63:557-61.
63. Turna B, Stein RJ, Smaldone MC, et al. Safety and efficacy of flexible ureterorenoscopy and holmium: YAG lithotripsy for intrarenal stones in anticoagulated cases. J Urol 2008;179:1415-9.
64. Eberli D, Chassot PG, Sulser T, et al. Urological surgery and antiplatelet drugs after cardiac and cerebrovascular accidents. J Urol 2010;183:2128-36.
65. Ala-Opas MY, Grönlund SS. Blood loss in long-term aspirin users undergoing transurethral prostatectomy. Scand J Urol Nephrol 1996;30:203-6. (Pubitemid 26228182)
66. Chernoguz A, Telem DA, Chu E, Ozao- Choy J, Tammaro Y, Divino CM. Cessation of clopidogrel before major abdominal procedures. Arch Surg 2011;146:334-9.
67. Leonidou A, Cam NB, Chambers IR. Femoral neck fractures in patients on clopidogrel. The effect of delaying surgery and the introduction of the new SIGN guidelines. Surgeon 2011;9:318-21.
68. Wiviott SD, Trenk D, Frelinger AL, et al.; PRINCIPLE-TIMI 44 Investigators. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial. Circulation 2007;116:2923-32. (Pubitemid 350291199)
69. Wiviott S, Braunwald E, McCabe C, et al.; TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-15. (Pubitemid 350106708)
70. Prasugrel (LY640315; CS-747) as an anti-thrombotic therapy in patients with acute coronary syndromes (ACS). NDA 22-307, EffientTM (prasugrel). Presentation to the Cardiovascular and Renal Drugs Advisory Committee. February 3, 2009. Available at http://www.fda.gov/ohrms/dockets/AC/ 09/slides/2009- 4412s1-02-sponsor.pdf [accessed March 29, 2012].
71. Gurbel PA, Bliden KP, Butler K, et al. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation 2009; 120:2577-85.
72. Wallentin L, Becker RC, Budaj A, et al.; PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-57.
73. Held C, Asenblad N, Bassand JP, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol 2011;57:672-84.
74. Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J Am Coll Cardiol 2007;49: 2145-50. (Pubitemid 46824115)
75. Riddell JW, Chiche L, Plaud B, Hamon M. Coronary stents and noncardiac surgery. Circulation 2007;116:e378-e382. (Pubitemid 350287111)
76. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 2007;50:e159-e241.
77. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004; 110:1168-76. (Pubitemid 39328205)
78. Grines CL, Bonow RO, Casey DE Jr, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and Ameri- can Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 2007;49:734-9. (Pubitemid 46210116)
79. Poldermans D, Bax JJ, Boersma E, et al.; Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery, European Society of Cardiology (ESC). Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 2009;30:2769-812.
80. Cardiac Society of Australia and New Zealand. Guidelines for the management of antiplatelet therapy in patients with coronary stents undergoing non-cardiac surgery. Heart Lung Circ 2010;19:2-10.
81. Douketis JD, Berger PB, Dunn AS, et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008;133(6 Suppl):299S-339S. (Pubitemid 351894915)
82. Samama CM, Bastien O, Forestier F, et al.; French Society of Anesthesiology and Intensive Care. Antiplatelet agents in the perioperative period: expert recommendations of the French Society of Anesthesiology and Intensive Care (SFAR) 2001 - summary statement. Can J Anaesth 2002;49:S26-S35.
83. Di Minno MN, Prisco D, Ruocco AL, Mastronardi P, Massa S, Di Minno G. Perioperative handling of patients on antiplatelet therapy with need for surgery. Intern Emerg Med 2009;4:279-88.
84. Korte W, Cattaneo M, Chassot PG, et al. Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group on Thrombosis of the European Society for Cardiology (ESC). Thromb Haemost 2011;105:743-9.
85. McDonald SB, Renna M, Spitznagel EL, et al. Preoperative use of enoxaparin increases the risk of postoperative bleeding and re-exploration in cardiac surgery patients. J Cardiothorac Vasc Anesth 2005;19: 4-10. (Pubitemid 40259702)
86. Windecker S, Meier B. Late coronary stent thrombosis. Circulation 2007;116: 1952-65. (Pubitemid 350287091)
87. Tsimikas S. Drug-eluting stents and late adverse clinical outcomes: lessons learned, lessons awaited. J Am Coll Cardiol 2006;47:2112-5.
88. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202. (Pubitemid 43929240)
89. Gwon HC, Hahn JY, Park KW, et al. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study. Circulation 2012;125:505-13.
90. Valgimigli M, Campo G, Percoco G, et al. Randomized comparison of 6- versus 24- month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention. Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY). Am Heart J 2010;160:804-11.
91. Heestermans AA, van Werkum JW, Zwart B, et al. Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: incidence, predictors and clinical outcome. J Thromb Haemost 2010;8:2385-93.
92. Urban P, Gershlick AH, Guagliumi G, et al.; e-Cypher Investigators. Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation 2006;113:1434-41. (Pubitemid 43739440)
93. Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 2006;113:1108-13.
94. Farb A, Boam AB. Stent thrombosis redux - the FDA perspective. N Engl J Med 2007;356:984-7. (Pubitemid 46376798)
95. Merlini PA, Bauer KA, Oltrona L, et al. Persistent activation of the coagulation mechanism in unstable angina and myocardial infarction. Circulation 1994;90:61-8. (Pubitemid 24203663)
96. Dunning J, Versteegh M, Fabbri A, et al.; EACTS Audit and Guidelines Committee. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 2008;34:73-92.
97. Cerfolio RJ, Minnich DJ, Bryant AS. General thoracic surgery is safe in patients taking clopidogrel (Plavix). J Thorac Cardiovasc Surg 2010;140:970-6.
98. Liapis CD, Bell PR, Mikhailidis D, et al.; ESVS Guidelines Collaborators. ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg 2009;37(4 Suppl):1-19.
99. Moll FL, Powell JT, Fraedrich G, et al.; European Society for Vascular Surgery. Management of abdominal aortic aneurysms clinical practice guidelines of the European Society for Vascular Surgery. Eur J Vasc Endovasc Surg 2011;41(Suppl 1):S1-S58.
100. Payne DA, Jones CI, Hayes PD, et al. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation 2004;109:1476-81. (Pubitemid 38420174)
101. Hamish M, Gohel MS, Shepherd A, Howes NJ, Davies AH. Variations in the pharmacological management of patients treated with carotid endarterectomy: a survey of European vascular surgeons. Eur J Vasc Endovasc Surg 2009;38:402-7.
102. Rosenbaum A, Rizvi AZ, Alden PB, et al. Outcomes related to antiplatelet or anticoagulation use in patients undergoing carotid endarterectomy. Ann Vasc Surg 2011;25:25-31.
103. Engelter S, Lyrer P. Antiplatelet therapy for preventing stroke and other vascular events after carotid endarterectomy. Cochrane Database Syst Rev 2003;(3): CD001458.
104. Neilipovitz DT, Bryson GL, Nichol G. The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis. Anesth Analg 2001;93:573-80. (Pubitemid 32783276)
105. Stone DH, Goodney PP, Schanzer A, et al.; Vascular Study Group of New England. Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery. J Vasc Surg 2011;54:779-84.
106. Fleming MD, Stone WM, Scott P, Chapital AB, Fowl RJ, Money SR. Safety of carotid endarterectomy in patients concurrently on clopidogrel. Ann Vasc Surg 2009; 23:612-5.
107. Payne DA, Twigg MW, Hayes PD, Naylor AR. Antiplatelet agents and risk factors for bleeding postcarotid endarterectomy. Ann Vasc Surg 2010;24:900-7.
108. Markus HS, Droste DW, Kaps M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005; 111:2233-40. (Pubitemid 40632440)
109. Sharpe RY, Dennis MJ, Nasim A, et al. Dual antiplatelet therapy prior to carotid endarterectomy reduces post-operative embolisation and thromboembolic events: post-operative transcranial Doppler monitoring is now unnecessary. Eur J Vasc Endovasc Surg 2010;40:162-7.
110. Luckie M, Khattar RS, Fraser D. Noncardiac surgery and antiplatelet therapy following coronary artery stenting. Heart 2009; 95:1303-8.
111. O'Riordan JM, Margey RJ, Blake G, O'Connell PR. Antiplatelet agents in the perioperative period. Arch Surg 2009;144:69-76.
112. Kotsovolis G, Komninos G, Kyrgidis A, Papadimitriou D. Preoperative withdrawal of antiplatelet treatment in lower limb vascular patients prior to surgical management under epidural or spinal anaesthesia: an evidence based approach and systematic review. Int Angiol 2010;29:475-81.
113. Boustière C, Veitch A, Vanbiervliet G, et al.; European Society og Gastrointestinal Endoscopy. Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2011;43:445-61.
114. Sawhney MS, Salfiti N, Nelson DB, Lederle FA, Bond JH. Risk factors for severe delayed postpolypectomy bleeding. Endoscopy 2008;40:115-9. (Pubitemid 351292212)
115. Shiffman ML, Farrel MT, Yee YS. Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDS. Gastrointest Endosc 1994;40: 458-62. (Pubitemid 24235576)
116. Whitson MJ, Dikman AE, von Althann C, et al. Is gastroduodenal biopsy safe in patients receiving aspirin and clopidogrel? A prospective, randomized study involving 630 biopsies. J Clin Gastroenterol 2011;45:228-33.
117. Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335: 909-18. (Pubitemid 26314443)
118. Kien-Fong Vu C, Chang F, Doig L, Meenan J. A prospective control study of the safety and cellular yield of EUS-guided FNA or Trucut biopsy in patients taking aspirin, nonsteroidal anti-inflammatory drugs, or prophylactic low molecular weight heparin. Gastrointest Endosc 2006;63:808-13. (Pubitemid 44294374)
119. Coronel M, Banner K, Nannegari V, Davidoff S, Jalal PK, Bank S. Does aspirin increase the risk of bleeding for percutaneous endoscopic gastrostomy procedure? Gastrointest Endosc 2006;63:AB113.
120. Richter JA, Patrie JT, Richter RP, et al. Use of high-dose aspirin or clopidogrel before or after percutaneous endoscopic gastrostomy is not associated with post-procedural bleeding. Gastrointest Endosc 2010; 71:AB114.
121. Kwan V, Bourke MJ, Williams SJ, et al. Argon plasma coagulation in the management of symptomatic gastrointestinal vascular lesions: experience in 100 consecutive patients with long-term follow-up. Am J Gastroenterol 2006;101:58-63. (Pubitemid 43381709)
122. Anderson MA, Ben-Menachem T, Gan SI, et al.; ASGE Standards of Practice Committee. Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc 2009;70:1060-70.
123. Veitch AM, Baglin TP, Gershlick AH, et al.; British Committee for
124. Heldwein W, Dollhopf M, Rösch T, et al.; Munich Gastroenterology Group. The Munich Polypectomy Study (MUPS): prospective analysis of complications and risk factors in 4000 colonic snare polypectomies. Endoscopy 2005;37:1116-22. (Pubitemid 41576669)
125. Kim HS, Kim TI, Kim WH, et al. Risk factors for immediate postpolypectomy bleeding of the colon: a multicenter study. Am J Gastroenterol 2006;101:1333-41. (Pubitemid 43830002)
126. Watabe H, Yamaji Y, Okamoto M, et al. Risk assessment for delayed hemorrhagic complication of colonic polypectomy: polyprelated factors and patient-related factors. Gastrointest Endosc 2006;64:73-8. (Pubitemid 43949387)
127. Rabeneck L, Paszat LF, Hilsden RJ, et al. Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology 2008; 135:1899-906.
128. Consolo P, Luigiano C, Strangio G, et al. Efficacy, risk factors and complications of endoscopic polypectomy: ten year experience at a single center. World J Gastroenterol 2008;14:2364-9. (Pubitemid 351877607)
129. Guerci Ph, Audibert G, Mertes PM. Management of chronic anticoagulant and antiplatelet treatment before scheduled neurosurgery. Neurochirurgie 2009;55:H17-H22.
130. Korinth MC. Low-dose aspirin before intracranial surgery - results of a survey among neurosurgeons in Germany. Acta Neurochir 2006;148:1189-96. (Pubitemid 44844284)
131. Lehot JJ, Piriou V, Durand de Gevigney G, Coriat P. Patient at risk of endocoronary stent thrombosis during perioperative period: a frequent situation. Ann Fr Anesth Reanim 2005;24:1247-9. (Pubitemid 41463408)
132. Di Roio C, Gaillac N, Pélissou I, Carillon R, Dailler F. Drug-eluting stent, intraventricular haemorrhage, ventricular drainage, favourable outcome. Ann Fr Anesth Reanim 2006;26:91-2. (Pubitemid 46072695)
133. Mantz J, Samama CM. The national STRATAGEM study: the success needs everyone's contribution! Ann Fr Anesth Reanim 2006;25:133-4. (Pubitemid 43207525)
134. Herth FJ, Becker HD, Ernst A. Aspirin does not increase bleeding complications after transbronchial biopsy. Chest 2002;122: 1461-4. (Pubitemid 35339567)
135. Chinsky K. Bleeding risk and bronchoscopy: in search of the evidence in evidence- based medicine. Chest 2005;127: 1875-7.
136. Johson JR, Chin R, Conforti J. Bronchoscopic myths and legends: anti-platelet medications. Clinical Pulmonary Medicine 2005;12:363-5. (Pubitemid 41689715)
137. Ernst A, Eberhardt R, Wahidi M, Becker HD, Herth FJ. Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest 2006;129:734-7.
138. Trosini-Désert V, Vergnon JM, Collet JP, Montalescot G, Similowski T; Groupe d'Endoscopie Bronchique de Langue Française. Fibreoptic bronchoscopy and antiplatelet agents: a risk-benefit analysis. Rev Mal Respir 2007;24:48-56.
139. Pototski M, Amenábar JM. Dental management of patients receiving anticoagulation or antiplatelet treatment. J Oral Sci 2007;49:253-8.
140. Elad S, Chackartchi T, Shapira L, Findler M. A critically severe gingival bleeding following non-surgical periodontal treatment in patients medicated with anti-platelet. J Clin Periodontol 2008;35:342-34.
141. Kalpidis CD, Setayesh RM. Hemorrhaging associated with endosseous implant placement in the anterior mandible: a review of the literature. J Periodontol 2004;75: 631-45. (Pubitemid 38811852)
142. Lillis T, Ziakas A, Koskinas K, Tsirlis A, Giannoglou G. Safety of dental extractions during uninterrupted single or dual antiplatelet treatment. Am J Cardiol 2011;108: 964-7.
143. Krishnan B, Shenoy NA, Alexander M. Exodontia and antiplatelet therapy. J Oral Maxillofac Surg 2008;66:2063-6.
144. Napenas JJ, Hong CH, Brennan MT, Furney SL, Fox PC, Lockhart PB. The frequency of bleeding complications after invasive dental treatment in patients receiving single and dual antiplatelet therapy. J Am Dent Assoc 2009;140:690-5.
145. Kobayashi H. Evaluation of the need to discontinue antiplatelet and anticoagulant medications before cataract surgery. J Cataract Refract Surg 2010;36:1115-9.
146. Barequet IS, Sachs D, Shenkman B, et al. Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy. J Cataract Refract Surg 2011;37:1434-8.
147. Mason JO 3rd, Frederick PA, Neimkin MG, et al. Incidence of hemorrhagic complications after intravitreal bevacizumab (avastin) or ranibizumab (lucentis) injections on systemically anticoagulated patients. Retina 2010;30:1386-9.
148. Kumar N, Jivan S, Thomas P, McLure H. Sub-Tenon's anesthesia with aspirin, warfarin, and clopidogrel. J Cataract Refract Surg 2006;32:1022-5. (Pubitemid 43949463)
149. Joseph JJ, Pillai A, Bramley D. Clopidogrel in orthopaedic patients: a review of current practice in Scotland. Thromb J 2007;5:6.
150. Collinge CA, Kelly KC, Little B, Weaver T, Schuster RD. The effects of clopidogrel (Plavix) and other oral anticoagulants on early hip fracture surgery. J Orthop Trauma 2012 Mar 21 [Epub ahead of print].
151. Kariotis I, Philippou P, Volanis D, Serafetinides E, Delakas D. Safety of ultrasound- guided transrectal extended prostate biopsy in patients receiving low-dose aspirin. Int Braz J Urol 2010;36:308-16.
152. Enver MK, Hoh I, Chinegwundoh FI. The management of aspirin in transurethral prostatectomy: current practice in the UK. Ann R Coll Surg Engl 2006;88:280-3.
153. Carmignani L, Picozzi S, Stubinski R, et al. Endoscopic resection of bladder cancer in patients receiving double platelet antiaggregant therapy. Surg Endosc 2011;25: 2281-7.
154. Newsome LT, Weller RS, Gerancher JC, Kutcher MA, Royster RL. Coronary artery stents: II. Perioperative considerations and management. Anesth Analg 2008;107:570-90.
155. Llau JV, Ferrandis R, Sierra P, Gomez-Luque A. Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update. Vasc Health Risk Manag 2010;6:855-67.
156. Frishman WH, Burns B, Atac B, Alturk N, Altajar B, Lerrick K. Novel antiplatelet therapies for treatment of patients with is- chemic heart disease: inhibitors of the platelet glycoprotein IIb/IIIa integrin receptor. Am Heart J 1995;130:877-92.
157. Turner NA, Moake JL, Kamat SG, et al. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa. Circulation 1995;91:1354-62.
158. Abualsaud AO, Eisenberg MJ. Perioperative management of patients with drugeluting stents. JACC Cardiovasc Interv 2010; 3:131-42.
159. Savonitto S, D'Urbano M, Caracciolo M, et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of "bridging" antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth 2010;104:285-91.
160. Wessler JD, Saldana F, Giugliano RP. Bridging therapy after recent stent implantation: case report and review of data. Cardiovasc Revasc Med 2012;13:30-8.
161. Pickett AM, Taylor DA, Ackman ML. Prolonged infusion of eptifibatide as bridge therapy between bare-metal stent insertion and cardiovascular surgery: case report and review of the literature. Pharmacotherapy 2010;30:127e-133e.
162. Bigalke B, Seizer P, Geisler T, Lindemann S, Gawaz M, May AE. Perioperative antiplatelet therapy in patients at risk for coronary stent thrombosis undergoing noncardiac surgery. Clin Res Cardiol 2009;98: 335-9.
163. Ceppa DP, Welsby IJ, Wang TY, et al. Perioperative management of patients on clopidogrel (Plavix) undergoing major lung resection. Ann Thorac Surg 2011;92:1971-6.
164. Angiolillo DJ, Firstenberg MS, Price MJ, et al.; BRIDGE Investigators. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. JAMA 2012;307:265-74.